Glipizide suppresses prostate cancer progression in the TRAMP model by inhibiting angiogenesis

Drug repurposing of non-cancer drugs represents an attractive approach to develop new cancer therapy. Using the TRAMP transgenic mouse model, glipizide, a widely used drug for type 2 diabetes mellitus, has been identified to suppress prostate cancer (PC) growth and metastasis. Angiogenesis is intima...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Cuiling, Bin Li, Yang, Yang, Yang, Yongxia, Li, Jialin, Zhou, Qin, Wen, Yinxin, Zeng, Cuiling, Zheng, Lingyun, Zhang, Qianqian, Li, Jiangchao, He, Xiaodong, Zhou, Jia, Shao, Chunkui, Wang, Lijing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4904209/
https://www.ncbi.nlm.nih.gov/pubmed/27292155
http://dx.doi.org/10.1038/srep27819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4904209/
https://www.ncbi.nlm.nih.gov/pubmed/27292155
http://dx.doi.org/10.1038/srep27819

Ejemplares similares